Dopaminergic NeuronsDopamineMesencephalonSubstantia NigraDieldrinParkinson Disease1-Methyl-4-phenylpyridiniumParkinsonian DisordersNeurons1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineAnacardic AcidsTyrosine 3-MonooxygenaseOxidopaminealpha-SynucleinDopamine AgentsProtein Kinase C-deltaParkinson Disease, SecondaryMPTP PoisoningCorpus StriatumNerve DegenerationCell DeathNeurotoxinsNeuroprotective AgentsBrainElectron Transport Complex IRats, Sprague-DawleyCaspase 3Oxidative StressDisease Models, AnimalDNA FragmentationMice, Inbred C57BLMotor ActivityMitochondriaReceptors, DopamineImmunohistochemistryDose-Response Relationship, DrugCells, CulturedApoptosisCell SurvivalReceptors, Dopamine D2Dopamine AgonistsDopamine AntagonistsCell LineDopamine Plasma Membrane Transport ProteinsNerve Tissue ProteinsReceptors, Dopamine D1Levodopa3,4-Dihydroxyphenylacetic AcidApomorphineNeuronal PlasticityVentral Tegmental AreaHippocampusSulpirideBehavior, AnimalNeostriatumNuclear Receptor Subfamily 4, Group A, Member 2Cerebral CortexBenzazepinesQuinpiroleHomovanillic AcidHaloperidolNitric Oxide Synthase Type ISynaptic TransmissionAntiparkinson AgentsRats, WistarNeurogenesisNeurogliaAdrenergic AgentsCell DifferentiationNeural PathwaysMice, KnockoutTime FactorsAnimals, NewbornAction PotentialsPC12 CellsAmphetamineAxons2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineMice, TransgenicVesicular Monoamine Transport ProteinsSignal TransductionNeuritesTegmentum MesencephaliCell CountAnalysis of VarianceDihydroxyphenylalanineCaudate NucleusNucleus AccumbensNeuronal Ceroid-LipofuscinosesMicrogliaBromocriptineBasal GangliaRewardReceptors, Dopamine D3MethamphetamineAstrocytesRacloprideSynapsesNerve Growth FactorsGlutamic Acid